Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025
Tactile Systems Technology (TCMD) has announced it will release its fourth quarter and fiscal year 2024 financial results after market close on February 18, 2025. The company will host a conference call with Q&A at 5:00 p.m. Eastern Time on the same day.
Participants can join via phone (877-407-3088 for domestic, 201-389-0927 for international) using access code 13751026. A live webcast will be available on the company's investor relations website, with a replay accessible for two weeks afterward.
Tactile Medical specializes in at-home therapies for chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease, focusing on helping patients manage their care at home.
Tactile Systems Technology (TCMD) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'anno fiscale 2024 dopo la chiusura del mercato il 18 febbraio 2025. L'azienda ospiterà una conference call con sessione di domande e risposte alle 17:00 ora orientale dello stesso giorno.
I partecipanti possono unirsi tramite telefono (877-407-3088 per chiamate nazionali, 201-389-0927 per chiamate internazionali) utilizzando il codice di accesso 13751026. Sarà disponibile anche una diretta streaming sul sito web delle relazioni con gli investitori dell'azienda, con una registrazione accessibile per due settimane dopo.
Tactile Medical si specializza in terapie domiciliari per condizioni croniche tra cui linfedema, lipedema, insufficienza venosa cronica e malattie polmonari croniche, concentrandosi sull'aiutare i pazienti a gestire la propria cura a casa.
Tactile Systems Technology (TCMD) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año fiscal 2024 después del cierre del mercado el 18 de febrero de 2025. La compañía llevará a cabo una conferencia telefónica con preguntas y respuestas a las 5:00 p.m. hora del Este el mismo día.
Los participantes pueden unirse por teléfono (877-407-3088 para llamadas nacionales, 201-389-0927 para internacionales) usando el código de acceso 13751026. También estará disponible una transmisión en vivo en el sitio web de relaciones con inversores de la compañía, con una grabación accesible durante dos semanas después.
Tactile Medical se especializa en terapias a domicilio para condiciones crónicas como linfedema, lipedema, insuficiencia venosa crónica y enfermedades pulmonares crónicas, enfocándose en ayudar a los pacientes a manejar su atención en casa.
촉각 시스템 기술(TCMD)은 2024 회계 연도 4분기 재무 결과를 2025년 2월 18일 시장 종료 후에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준으로 오후 5시에 질의응답이 포함된 전화 회의를 개최합니다.
참가자는 전화(국내 877-407-3088, 국제 201-389-0927)를 통해 접속 코드 13751026을 사용하여 참여할 수 있습니다. 회사의 투자자 관계 웹사이트에서 라이브 웹캐스트가 제공되며, 그 후 2주 동안 다시 플레이할 수 있습니다.
Tactile Medical은 림프 부종, 지방 부종, 만성 정맥 부족증 및 만성 폐 질환을 포함한 만성 질환을 위한 가정용 치료에 전문화되어 있으며, 환자가 자택에서 치료 관리할 수 있도록 돕는 데 중점을 두고 있습니다.
Tactile Systems Technology (TCMD) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'exercice fiscal 2024 après la fermeture du marché le 18 février 2025. L'entreprise animera une conférence téléphonique avec questions et réponses à 17h00, heure de l'Est, le même jour.
Les participants peuvent rejoindre par téléphone (877-407-3088 pour les appels nationaux, 201-389-0927 pour les internationaux) en utilisant le code d'accès 13751026. Un webinaire en direct sera disponible sur le site web des relations avec les investisseurs de l'entreprise, avec un replay accessible pendant deux semaines après.
Tactile Medical se spécialise dans les thérapies à domicile pour des conditions chroniques telles que le lymphœdème, le lipœdème, l'insuffisance veineuse chronique et les maladies pulmonaires chroniques, en se concentrant sur l'aide apportée aux patients pour gérer leurs soins à domicile.
Tactile Systems Technology (TCMD) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 nach Marktschluss am 18. Februar 2025 veröffentlichen wird. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz mit Fragen und Antworten veranstalten.
Teilnehmer können sich telefonisch (877-407-3088 für nationale Anrufe, 201-389-0927 für internationale Anrufe) mit dem Zugangscode 13751026 einwählen. Ein Live-Webcast wird auf der Investoren-Website des Unternehmens verfügbar sein, wobei eine Wiederholung zwei Wochen lang zugänglich ist.
Tactile Medical ist auf die Therapie zu Hause für chronische Erkrankungen wie Lymphödeme, Lipödeme, chronische venöse Insuffizienz und chronische Lungenerkrankungen spezialisiert und konzentriert sich darauf, den Patienten zu helfen, ihre Pflege zu Hause zu verwalten.
- None.
- None.
MINNEAPOLIS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2024 financial results will be released after the market closes on Tuesday, February 18, 2025.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on February 18, 2025, to discuss the results of the quarter and fiscal year. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13751026. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13751026. The webcast will be archived at investors.tactilemedical.com.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
When will Tactile Medical (TCMD) release Q4 and FY 2024 earnings?
How can investors access TCMD's Q4 2024 earnings call?
What is the replay information for TCMD's Q4 2024 earnings call?
What medical conditions does Tactile Medical (TCMD) treat?
